OncoCyte Corp

Company Snapshot
15 Cushing
Irvine, CA 92618
United States
Sector: Healthcare
Industry: Diagnostics & Research
Full Time Employees: 46
https://www.oncocyte.com
Please select from the dropdown
  1. Executive Compensation
  2. > OncoCyte Corp
Company Financials

2021
2022
2023
Gross Profit
$188,000
-$18,000
$413,000
Operating Income
-$46,946,000
-$28,852,000
-$22,417,000
Net Income
-$64,097,000
-$72,902,000
-$27,781,000
2021
Gross Profit
$188,000
Operating Income
-$46,946,000
Net Income
-$64,097,000
2022
Gross Profit
-$18,000
Operating Income
-$28,852,000
Net Income
-$72,902,000
2023
Gross Profit
$413,000
Operating Income
-$22,417,000
Net Income
-$27,781,000
The above data on OncoCyte Corp came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Joshua Riggs
Director, President and Chief Executive Officer
$456,846
$220,284
$47,780
$724,910
Joshua Riggs
$724,910
Director, President and Chief Executive Officer
Ekkehard Schutz
Chief Science Officer
$374,728
$165,892
$34,547
$575,167
Ekkehard Schutz
$575,167
Chief Science Officer
James Liu
Interim Principal Financial Officer, Senior Director, Controller and Principal Accounting Officer
$244,260
$44,681
$15,572
$304,513
James Liu
$304,513
Interim Principal Financial Officer, Senior Director, Controller and Principal Accounting Officer
Louis Silverman
Lead Independent Director
$73,500
$24,196
$0
$97,696
Louis Silverman
$97,696
Lead Independent Director
OncoCyte Corp listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us